Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats

P. Palsamy, S. Subramanian

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Resveratrol, a ubiquitous stress-induced phytoalexin, has demonstrated a wide variety of biological activities which make it a good candidate for the treatment of diabetes mellitus. The present study was aimed to evaluate its therapeutic potential by assaying the activities of key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. The daily oral treatment of resveratrol (5 mg/kg body weight) to diabetic rats for 30 days demonstrated a significant (p < 0.05) decline in blood glucose and glycosylated hemoglobin levels and a significant (p < 0.05) increase in plasma insulin level. The altered activities of the key enzymes of carbohydrate metabolism such as hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glucose-6-phosphate dehydrogenase, glycogen synthase and glycogen phosphorylase in liver and kidney tissues of diabetic rats were significantly (p < 0.05) reverted to near normal levels by the administration of resveratrol. Further, resveratrol administration to diabetic rats improved hepatic glycogen content suggesting the antihyperglycemic potential of resveratrol in diabetic rats. The obtained results were compared with glyclazide, a standard oral hypoglycemic drug. Thus, the modulatory effects of resveratrol on attenuating these enzymes activities afford a promise for widespread use for treatment of diabetes in the future.

Original languageEnglish (US)
Pages (from-to)356-362
Number of pages7
JournalChemico-Biological Interactions
Volume179
Issue number2-3
DOIs
StatePublished - May 15 2009

Fingerprint

Niacinamide
Carbohydrate Metabolism
Enzyme activity
Streptozocin
Rats
Enzymes
Medical problems
Hypoglycemic Agents
Gliclazide
Fructose-Bisphosphatase
Glycogen Phosphorylase
Glucose-6-Phosphatase
Glycogen Synthase
Liver Glycogen
Hexokinase
Pyruvate Kinase
Glucosephosphate Dehydrogenase
Glycosylated Hemoglobin A
Bioactivity
L-Lactate Dehydrogenase

Keywords

  • Carbohydrate metabolism
  • Diabetes mellitus
  • Nicotinamide
  • Resveratrol
  • Streptozotocin

ASJC Scopus subject areas

  • Toxicology

Cite this

@article{514ea78c1be9421b96073152d0c5e69d,
title = "Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats",
abstract = "Resveratrol, a ubiquitous stress-induced phytoalexin, has demonstrated a wide variety of biological activities which make it a good candidate for the treatment of diabetes mellitus. The present study was aimed to evaluate its therapeutic potential by assaying the activities of key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. The daily oral treatment of resveratrol (5 mg/kg body weight) to diabetic rats for 30 days demonstrated a significant (p < 0.05) decline in blood glucose and glycosylated hemoglobin levels and a significant (p < 0.05) increase in plasma insulin level. The altered activities of the key enzymes of carbohydrate metabolism such as hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glucose-6-phosphate dehydrogenase, glycogen synthase and glycogen phosphorylase in liver and kidney tissues of diabetic rats were significantly (p < 0.05) reverted to near normal levels by the administration of resveratrol. Further, resveratrol administration to diabetic rats improved hepatic glycogen content suggesting the antihyperglycemic potential of resveratrol in diabetic rats. The obtained results were compared with glyclazide, a standard oral hypoglycemic drug. Thus, the modulatory effects of resveratrol on attenuating these enzymes activities afford a promise for widespread use for treatment of diabetes in the future.",
keywords = "Carbohydrate metabolism, Diabetes mellitus, Nicotinamide, Resveratrol, Streptozotocin",
author = "P. Palsamy and S. Subramanian",
year = "2009",
month = "5",
day = "15",
doi = "10.1016/j.cbi.2008.11.008",
language = "English (US)",
volume = "179",
pages = "356--362",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats

AU - Palsamy, P.

AU - Subramanian, S.

PY - 2009/5/15

Y1 - 2009/5/15

N2 - Resveratrol, a ubiquitous stress-induced phytoalexin, has demonstrated a wide variety of biological activities which make it a good candidate for the treatment of diabetes mellitus. The present study was aimed to evaluate its therapeutic potential by assaying the activities of key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. The daily oral treatment of resveratrol (5 mg/kg body weight) to diabetic rats for 30 days demonstrated a significant (p < 0.05) decline in blood glucose and glycosylated hemoglobin levels and a significant (p < 0.05) increase in plasma insulin level. The altered activities of the key enzymes of carbohydrate metabolism such as hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glucose-6-phosphate dehydrogenase, glycogen synthase and glycogen phosphorylase in liver and kidney tissues of diabetic rats were significantly (p < 0.05) reverted to near normal levels by the administration of resveratrol. Further, resveratrol administration to diabetic rats improved hepatic glycogen content suggesting the antihyperglycemic potential of resveratrol in diabetic rats. The obtained results were compared with glyclazide, a standard oral hypoglycemic drug. Thus, the modulatory effects of resveratrol on attenuating these enzymes activities afford a promise for widespread use for treatment of diabetes in the future.

AB - Resveratrol, a ubiquitous stress-induced phytoalexin, has demonstrated a wide variety of biological activities which make it a good candidate for the treatment of diabetes mellitus. The present study was aimed to evaluate its therapeutic potential by assaying the activities of key enzymes of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. The daily oral treatment of resveratrol (5 mg/kg body weight) to diabetic rats for 30 days demonstrated a significant (p < 0.05) decline in blood glucose and glycosylated hemoglobin levels and a significant (p < 0.05) increase in plasma insulin level. The altered activities of the key enzymes of carbohydrate metabolism such as hexokinase, pyruvate kinase, lactate dehydrogenase, glucose-6-phosphatase, fructose-1,6-bisphosphatase, glucose-6-phosphate dehydrogenase, glycogen synthase and glycogen phosphorylase in liver and kidney tissues of diabetic rats were significantly (p < 0.05) reverted to near normal levels by the administration of resveratrol. Further, resveratrol administration to diabetic rats improved hepatic glycogen content suggesting the antihyperglycemic potential of resveratrol in diabetic rats. The obtained results were compared with glyclazide, a standard oral hypoglycemic drug. Thus, the modulatory effects of resveratrol on attenuating these enzymes activities afford a promise for widespread use for treatment of diabetes in the future.

KW - Carbohydrate metabolism

KW - Diabetes mellitus

KW - Nicotinamide

KW - Resveratrol

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=62549115284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549115284&partnerID=8YFLogxK

U2 - 10.1016/j.cbi.2008.11.008

DO - 10.1016/j.cbi.2008.11.008

M3 - Article

C2 - 19059388

AN - SCOPUS:62549115284

VL - 179

SP - 356

EP - 362

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

IS - 2-3

ER -